Which factors drive the choice of the French-speaking Quebec population towards a COVID-19 vaccination programme: A discrete-choice experiment

被引:1
|
作者
Morillon, Gabin F. [1 ]
Poder, Thomas G. [2 ]
机构
[1] Univ Montpellier, Montpellier Rech Econ, Ave Raymond Dugrand, Montpellier, France
[2] Univ Montreal, Sch Publ Hlth, Dept Management Evaluat & Hlth Policy, 7101 Parc Ave, Montreal, PQ H3N 1X9, Canada
关键词
COVID-19; discrete-choice; health economics; hesitancy; preferences; Quebec; vaccine; ATTRIBUTE NON-ATTENDANCE; LOGIT-MODELS; HESITANCY; HEALTH; PREFERENCES; COHERENCE; COMMAND; SENSE;
D O I
10.1111/hex.13963
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
ObjectivesThe aims of this study were to elicit preferences about the coronavirus disease 2019 (COVID-19) vaccine campaign in the general French-speaking adult Quebec population and to highlight the characteristics of the vaccine campaign that were of major importance.MethodsA discrete-choice experiment (DCE) was conducted between April and June 2021, in Quebec, Canada. A quota sampling method by age, gender and educational level was used to achieve a representative sample of the French-speaking adult population. The choice-based exercise was described by seven attributes within a vaccine campaign scenario. A mixed logit (MXL) model and a latent class logit (LCL) model were used to derive utility values. Age, gender, educational level, income and fear of COVID-19 were included as independent variables in the LCL.ResultsA total of 1883 respondents were included for analysis, yielding 22,586 choices. From these choices, 3425 (15.16%) were refusals. In addition, 1159 (61.55%) individuals always accepted any of the vaccination campaigns, while 92 individuals (4.89%) always refused vaccine alternatives. According to the MXL, relative weight importance of attributes was effectiveness (32.50%), risk of side effects (24.76%), level of scientific evidence (22.51%), number of shots (15.73%), priority population (3.60%), type of vaccine (0.61%), and vaccination location (0.28%). Four classes were derived from the LCL model and attributes were more or less important according to them. Class 1 (19.8%) was more concerned about the effectiveness (27.99%), safety (24.22%) and the number of shots (21.82%), class 2 (55.3%) wanted a highly effective vaccine (40.16%) and class 3 (17.6%) gave high value to the scientific evidence (42.00%). Class 4 preferences (7.4%) were more balanced, with each attribute having a relative weight ranging from 1.84% (type of vaccine) to 21.32% (risk of side effects). Membership posterior probabilities to latent classes were found to be predicted by individual factors such as gender, annual income or fear of COVID-19.ConclusionsVaccination acceptance relies on multiple factors. This study allowed assessment of vaccination-specific issues through a choice-based exercise and description of factors influencing this choice by segmenting the sample and drawing profiles of individuals. Moreover, besides effectiveness and safety, a major point of this study was to show the importance given by the general population to the level of scientific evidence surrounding vaccines.Patient or Public ContributionA small group of citizens was involved in the conception, design and interpretation of data. Participants of the DCE were all from the general population.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Public Preferences for a COVID-19 Vaccination Program in Quebec: A Discrete Choice Experiment
    Morillon, Gabin F.
    Poder, Thomas G.
    PHARMACOECONOMICS, 2022, 40 (03) : 341 - 354
  • [2] Preference of young adults for COVID-19 vaccination in the United Kingdom: a discrete choice experiment
    Boger, Sophie
    van Bergen, Ilja
    Beaudart, Charlotte
    Cheung, Kei Long
    Hiligsmann, Mickael
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (08) : 921 - 931
  • [3] Student COVID-19 vaccination preferences in China: A discrete choice experiment
    Wang, Siyuan
    Maitland, Elizabeth
    Wang, Tiantian
    Nicholas, Stephen
    Leng, Anli
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [4] A Discrete Choice Analysis Comparing COVID-19 Vaccination Decisions for Children and Adults
    Prosser, Lisa A.
    Wagner, Abram L.
    Wittenberg, Eve
    Zikmund-Fisher, Brian J.
    Rose, Angela M.
    Pike, Jamison
    JAMA NETWORK OPEN, 2023, 6 (01) : e2253582
  • [5] Location, location, location: a discrete choice experiment to inform COVID-19 vaccination programme delivery in the UK
    McPhedran, Robert
    Gold, Natalie
    Bemand, Charlotte
    Weston, Dale
    Rosen, Rachel
    Scott, Robert
    Chadborn, Tim
    Amlot, Richard
    Mawby, Max
    Toombs, Ben
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [6] Location, location, location: a discrete choice experiment to inform COVID-19 vaccination programme delivery in the UK
    Robert McPhedran
    Natalie Gold
    Charlotte Bemand
    Dale Weston
    Rachel Rosen
    Robert Scott
    Tim Chadborn
    Richard Amlôt
    Max Mawby
    Ben Toombs
    BMC Public Health, 22
  • [7] Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment
    Jonathan Sicsic
    Serge Blondel
    Sandra Chyderiotis
    François Langot
    Judith E. Mueller
    The European Journal of Health Economics, 2023, 24 : 81 - 98
  • [8] Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment
    Sicsic, Jonathan
    Blondel, Serge
    Chyderiotis, Sandra
    Langot, Francois
    Mueller, Judith E.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2023, 24 (01) : 81 - 98
  • [9] Malaysian public preferences and decision making for COVID-19 vaccination: A discrete choice experiment
    Teh, Hoon Shien
    Woon, Yuan Liang
    Leong, Chin Tho
    Hing, Nicholas Yee Liang
    Mien, Teresa Yong Sui
    Roope, Laurence S. J.
    Clarke, Philip M.
    Lim, Lee -Ling
    Buckell, John
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2022, 27
  • [10] Attribute nonattendance in COVID-19 vaccine choice: A discrete choice experiment based on Chinese public preference
    Xiao, Jianhong
    Wang, Fei
    Wang, Min
    Ma, Zegang
    HEALTH EXPECTATIONS, 2022, 25 (03) : 959 - 970